Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Pennington Biomedical Research Center · Louisiana State University Health Sciences Center New Orleans · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
722
total citations
- FWCI
- 57.61
- Percentile
- 100%
- References
- 32
Citations per year
Authors
9- WTWilliam T. CefaluCorresponding
Pennington Biomedical Research Center, Louisiana State University Health Sciences Center New Orleans
- LALawrence A. Leiter
University of Toronto, St. Michael's Hospital
- KYKun‐Ho Yoon
Seoul St. Mary's Hospital, Catholic University of Korea
- PAPablo Arias
National University of Rosario
- LNLeo Niskanen
University of Eastern Finland
Topics & keywords
Topics
Keywords
- Glimepiride
- Medicine
- Canagliflozin
- Metformin
- Type 2 diabetes
- Population
- Internal medicine
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.